Non-celiac wheat sensitivity (WS) is considered a new clinical entity. An increasing percentage of the general population avoids gluten ingestion. However, the real existence of this condition is debated and specifi c markers are lacking. Our aim was thus to demonstrate the existence of WS and defi ne its clinical, serologic, and histological markers.
INTRODUCTION
Celiac disease (CD) prevalence is estimated to be near to 1:100 in Western countries ( 1 -3 ) . However, a much higher percentage of the general population than this 1 % consider themselves to be suffering from wheat sensitivity (WS) and exclude wheat from their diet on the basis of their negative experience aft er eating wheat-containing foods. Th ese wheat-reactive patients oft en present symptoms similar to CD but have negative CD serology and histopathology.
In most cases, they consult a number of physicians, seeking to " reach " a diagnosis of CD but, very oft en, they are considered to be " simply " suff ering from irritable bowel syndrome (IBS) ( 4 ) . Th e diagnostic " gold standard " for WS ought to be the double-blind placebocontrolled (DBPC) challenge, but this is a quite cumbersome and time-consuming method and is therefore very rarely used.
In this retrospective study, we report the characteristics of all the patients with an IBS-like clinical presentation, who had received a Non-Celiac Wheat Sensitivity Diagnosed by Double-Blind Placebo-Controlled Challenge: Exploring a New Clinical Entity defi nitive diagnosis of WS on the basis of a DBPC challenge in our centers in previous years.
Aims of the study were: (i) to demonstrate the existence of nonceliac WS as a defi ned clinical condition and (ii) to identify the clinical, serological, and histological characteristics, which could distinguish patients with non-CD WS from IBS and from CD patients.
METHODS
We reviewed the clinical charts of all patients with an IBS-like clinical presentation attending the outpatient center of the Department of Internal Medicine at the University Hospital of Palermo and the Department of Internal Medicine of the Hospital of Sciacca who had been diagnosed with WS between January 2001 and June 2011.
Inclusion and exclusion criteria
We included only patients who fulfi lled the criteria recently proposed by the experts ' meeting on " gluten sensitivity " ( 5, 6 ) . In brief, the patients met all the following inclusion criteria:
(i) IBS-like symptoms defi ned according to the Rome II criteria ( 7 ) . Additional inclusion criteria were: (i) age > 18 years; (ii) follow-up duration longer than 8 months aft er the initial diagnosis; (iii) > 2 outpatient visits during the follow-up period. Exclusion criteria were: (i) IgA defi ciency; (ii) self-exclusion of wheat from the diet; (iii) lack of DBPC-challenge method in the diagnosis.
Diagnostic procedures
In all cases, WS or multiple food hypersensitivity was diagnosed aft er the exclusion of other diagnoses. Consequently, the diagnostic workup of the patients may also have included abdominal ultrasonography, colonoscopy, histological examination of the recto-colon mucosa, small intestine barium examination, and H2 breath test.
Immunologic assays and HLA typing for CD
All patients underwent serum anti-tTG and EmA IgA, anti-gliadin (AGA) IgA and IgG assays performed using commercial kits (Eu.tTG. IgA, anti-Gliadin IgA and IgG, and anti-endomisio, Eurospital Pharma, Trieste, Italy), and reference values were determined as described previously ( 8, 9 ) .
Most patients also underwent EmA assay in the culture medium of the intestinal biopsies ( 10,11 ). Patients were also typed for HLA-DQ phenotypes by PCR using sequence-specifi c primers, with a DR and DQ sequence-specifi c primers kit (Unipath SpA, Milan, Italy) or a rapid method (DQ-CD Typing Plus by BioDiaGene, Palermo, Italy) ( 12 ) .
Histology studies
Duodenal histology . In accordance with a standard diagnostic protocol, four to six biopsy specimens were obtained from the second duodenal portion during gastroduodenoscopy. Th e slides were stained with hematoxylin and eosin and graded according to the standardized scheme reported by Oberhuber et al. ( 13 ) . Th e number of intra-epithelial lymphocytes (IELs) per 100 villous epithelial cells was assessed by immunohistochemical staining: CD3 + IELs were stained with monoclonal antibody Leu-4. Th e upper limit of the reference interval in our laboratory was 25 IELs / 100 epithelial cells. Th e number of eosinophils (EOS) per high-power fi eld ( × 40) was also assessed; the upper limit of the reference interval in our laboratory was 60 EOS / 10 high-power fi elds.
Other sites of histology examinations . In all the patients who underwent colonoscopy, biopsies were performed in the ileum and in diff erent parts of the colon, according to a standard procedure ( 14 ) . IELs and EOS were counted at a high-power fi eld ( × 40) in cross-sections of 50 crypts randomly selected from each slide and these cell numbers were expressed per 100 deep-crypt epithelial cells. Th e EOS count in the lamina propria was expressed as a percentage of EOS per 1,000 lamina propria cells per section (fi ve sections per biopsy were examined). On the basis of the mean values + 2 s.d. observed in the colon biopsies of the control subjects, the upper limits of the reference interval in our laboratory were: intra-epithelial lymphocytes < 7, intra-epithelial EOS < 4, and lamina propria EOS < 9.
Allergology tests
Specifi c (RAST) IgE and / or skin prick tests to food allergens, as well as serum anti-β lactoglobulin IgG assays were performed in all patients, as previously described ( 15 ) . Many patients underwent a fl ow cytometric basophil activation test, based on the demonstration of altered membrane phenotypes on allergen-activated basophils ( 16 ) (for details see Supplementary Information ).
Elimination diet and DBPC-challenge method
At entry to the study, those patients who had self-reduced wheat consumption were invited to assume a minimum quantity of 30 g of wheat daily and were observed for 2 -4 weeks on a regular diet. All patients then commenced a standard elimination diet, based on our previous experience ( 14, 16 ) , with the exclusion of wheat, cow ' s milk, eggs, tomato, and chocolate. Patients selfreporting food hypersensitivity were also asked to avoid ingestion and / or contact with the food(s) causing symptoms. A previously validated questionnaire was used to assess self-reported food hypersensitivity ( 16 ) .
Furthermore, food diaries were maintained by the patients during the above periods to assess dietary intake and adherence to the diet.
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Aft er 4 weeks on elimination diet, they underwent DBPC challenges. Th e challenges were performed with the reintroduction of a single food at a time. Details about DBPC challenges are given in the Supplementary Information online. In the case of wheat, the DBPC challenge was performed with capsules coded A or B containing wheat or xylose, respectively. Capsules A or B were given for 2 consecutive weeks and then aft er 1 week of washout the patients received the other capsules for another 2 weeks (crossover design).
During all the phases of the study, including the challenge period, the severity of symptoms was recorded: the patients completed a 100-mm visual analog scale, with 0 representing no symptoms, which assessed overall symptoms and the specifi c symptoms they each reported.
DBPC challenge for cow ' s milk proteins was performed with an identical method, according to a standard protocol ( 15, 16 ) , at least 4 weeks before or aft er wheat challenge and when the visual analog scale (VAS) score was < 10, on elimination diet.
Th e challenges were stopped when clinical reactions occurred (increase in VAS score > 30) for at least two consecutive days (onset of abdominal discomfort or pain, associated with a change in stool frequency and / or appearance). Th e challenges were considered positive if the same symptoms, which had been initially presented, reappeared aft er their disappearance on elimination diet.
Challenges for other foods in patients with suspected multiple food hypersensitivity were performed in an open manner.
Two control groups were selected. One was composed of 50 patients with IBS who were classifi ed as not suff ering from wheat and food sensitivity, as they resulted negative at the DBPC challenges. Th ese subjects were selected at random from those who underwent elimination diet and DBPC challenge during the same years.
Th e second control group was composed of 100 CD patients showing gastrointestinal symptoms, selected at random from those diagnosed according to standard criteria ( 1 ) during the same years and in the same clinical units where the wheat-sensitive patients were diagnosed.
Statistical analysis
Th e sample size was calculated to compare the clinical, laboratory, and histological characteristics of the study groups. Choosing an error of 0.05 (alpha error) and, considering that the prevalence of gluten sensitivity has been reported to be about 6 % in a tertiary care center for CD diagnosis ( 6 ), choosing a delta error of 0.03, the number of patients to select will be given by the following calculation: (1.96 2 × 0.06 × 0.94) / 0.03 2 = 240 ( 17 ). When data distribution was Gaussian, values were expressed as mean ± s.d. and diff erences between the two groups were calculated using the Student ' s t -test. Analysis of variance for unpaired data was used to compare data with a Gaussian distribution from more than two groups. When a signifi cant diff erence was found, intergroup comparisons ( post hoc analysis) were made with the Bonferroni test.
When data distribution was non-Gaussian, values were expressed as median (minimum -maximum) and diff erences between the two groups were calculated using the Mann -Whitney U -test. Th e Kruskal -Wallis one-way analysis of variance by ranks was used to compare data with a non-Gaussian distribution from more than two groups. When a signifi cant diff erence was found, intergroup comparisons ( post hoc analysis) were made with the MannWhitney U -test with a Bonferroni correction.
Th e analysis for pairwise data was performed using the Wilcoxon rank sum test, as the distribution of data was non-Gaussian.
Th e χ 2 test or Fisher ' s exact test was used to test the frequencies. SPSS soft ware package (version 16.0; Chicago, IL) was used for statistical analysis.
Th e study was approved by the Ethics Committee of the University Hospital of Palermo.
RESULTS
During the study period, 920 patients with IBS diagnosis underwent the elimination diet and subsequent DBPC challenge ( Figure 1 ); of these, 276 (30 % ) were suff ering from WS as they became asymptomatic (VAS score < 10) on elimination diet and showed symptoms again (increase in VAS score > 30) during the DBPC challenge.
Seventy patients were diagnosed with WS alone (group 1) and two hundred and six were diagnosed with multiple food hypersensitivity, including WS (group 2), as they also reacted to the DBPC challenge with cow ' s milk proteins. Th e patients suff ering from WS alone (group 1) showed a clinical reaction to wheat challenge aft er a median time of 3 days (range: 3 h to 9 days), whereas those with multiple food hypersensitivity (group 2) reacted aft er a median of 2.5 days (range: 2 h to 5 days; Mann -Whitney; P < 0.01). Ten patients in group 1 and thirty-two in group 2 did not complete the 2-week challenge period due to the severity of symptoms, all when they were consuming wheat. No patients reacted to placebo. Figure 2 shows the overall symptom score and the score for abdominal pain, bloating, and changes in stool consistency in the 276 patients suff ering from WS, considered as a whole group. Th e VAS score for each symptom was signifi cantly higher than at baseline (on the wheat-free diet) from the fi rst week on the wheatcontaining diet ( P < 0.0001; Wilcoxon rank sum test) and the values further increased at the end of the second week ( P < 0.0001). On placebo, there was no signifi cant variation in the VAS score over baseline aft er weeks 1 and 2. Th e score on the wheat-containing diet was signifi cantly higher than on placebo both at the end of the fi rst and second weeks into DBPC challenge ( P < 0.0001; Mann -Whitney).
None of the patients suff ering from WS showed increased indexes of infl ammation, such as serum C-reactive protein, erythrocyte sedimentation rate, or high white blood cell count, either before or aft er the challenges.
None of the patients suff ering from WS alone (group 1) reacted to the DBPC challenge with cow ' s milk proteins and no other foods caused clinical symptoms. On the contrary, all patients with multiple food hypersensitivity (group 2) reacted to the DBPC cow ' s milk protein challenge: symptoms, time, and severity of the reaction were similar to those described for the wheat challenge. Th e absence of lactose ingestion during the challenge excluded COLON/SMALL BOWEL Non-Celiac Wheat Sensitivity the possibility that lactose intolerance could be responsible for the reappearance of symptoms. Furthermore, the patients in group 2 also showed symptoms when eating several foods, the most common being eggs (120 cases) and tomato (112 cases). Table 1 summarizes the demographic and clinical characteristics of the two patient groups suff ering from WS compared with the control groups of CD patients and IBS.
When we considered the 276 patients suff ering from WS as a whole group, they showed an anemia (most sideropenic anemia) and weight loss frequency intermediate between the CD and IBS control groups and a higher frequency of coexistent atopic diseases, self-reported wheat intolerance, and history of food allergy in infancy than both the CD and IBS controls ( Table 2 ) . Furthermore, wheat-sensitive patients had undergone a higher number of previous gastrointestinal endoscopy examinations (esophagogastroduodenoscopy plus colonoscopy) than the CD and IBS controls ( P < 0.001 for both groups) during their lives. Table 3 shows the results of the serum AGA, HLA typing, and immuno-allergy tests. Th e patients with WS showed a quite high frequency of positive serum IgG and IgA AGA. However, the allergy assay that tested positive most frequently was the cytometric basophil activation test. Among the wheat-sensitive patients, a small subgroup showed positive EmA assay in the culture medium of the duodenal biopsies. Table 4 shows the duodenal and colon histology fi ndings in the study groups. In accordance with the exclusion criteria, no patients suff ering from WS showed intestinal villous atrophy, whereas all the CD patients showed various degrees of villous atrophy. Th ere was a very high frequency of duodenal lymphocytosis in patients with WS and DQ2-and / or DQ8-positive patients showed a higher CD3 number than those DQ2 / DQ8 negatives (49 + 9 vs. 40 + 6 IEL / 100EC; t = 9.6; P < 0.0001). Furthermore, WS patients showed duodenal intra-epithelial EOS infi ltrate. Lymphocytic infl ammation of the colon mucosa was less frequent than in the duodenum in wheat-sensitive patients. On the contrary, EOS infi ltration of the colonic mucosa characterized two-third of wheat-sensitive patients ( Figure 3 ). In patients with multiple food hypersensitivity, the Figure 1 . Study design. The clinical charts of 920 patients fulfi ling the Rome II criteria for irritable bowel syndrome (IBS) diagnosis and the criteria for the diagnosis of " gluten sensitivity " ( 6 ) were revised. All patients underwent at least 4 weeks of elimination diet (exclusion of wheat, cow ' s milk and derivatives, eggs, tomato, and chocolate). Then they underwent double-blind placebo-controlled (DBPC) wheat challenge and 276 (30 % ) reacted to the challenge. All these patients went back on the same elimination diet and after 4 weeks underwent DBPC cow ' s milk protein challenge. Seventy patients did not react to the challenge and subsequently re-introduced all the other foods -except wheat -without any problems: these patients composed group 1 (wheat-sensitive patients). Two hundred and six patients also reacted to cow ' s milk protein challenge: these patients composed group 2 (multiple food-sensitive patients). basophil activation tests ( P < 0.0001) in the patients with multiple food hypersensitivity than in those with WS alone. In patients with multiple food sensitivity, histology showed a signifi cantly higher EOS infi ltration of the duodenal and colonic mucosa than in patients with WS alone.
DISCUSSION
Although there is increasing recognition that gluten ingestion can also cause various disorders, mainly IBS-like ones outside the criteria for a CD diagnosis ( 4 ), very few studies have been performed in this fi eld.
WS is frequently perceived by the patients themselves and they consult physicians seeking to reach a defi nite diagnosis of CD or " at least " of wheat hypersensitivity but this is generally opposed as the patients do not fulfi ll the CD diagnostic criteria ( 1 ) and do not show laboratory assays documenting an IgE-mediated food allergy. On the other hand, the emotional role is known to be pivotal in IBS patients ( 18, 19 ) , consequently the clinical response severity of intra-epithelial EOS and lymphocytic infi ltration gradually decreased from the ileum to the rectum (data not shown).
Histologic examination showed a uniformly normal crypt architecture, normal goblet cell number, and absence of granulomata or parasites.
Finally, Table 5 shows the clinical, serologic, and histologic characteristics that diff ered between patients with WS alone and those with multiple food sensitivity. Patients with WS alone (group 1), when compared with patients with multiple food sensitivity (group 2) showed a higher frequency of anemia and weight loss, and of the HLA haplotypes DQ2 or DQ8. EmA assay in the culture medium of the intestinal biopsies was positive in about one-third of the patients with WS alone, whereas none of the group 2 patients tested positive. Patients with multiple food sensitivity showed a higher frequency of coexistent atopic disease and self-reported wheat intolerance ( P < 0.0001).
Th ere was a signifi cantly higher frequency of positive serum IgG anti-betalactoglobulin ( P < 0.01) and of positive fl ow cytometric 
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to an elimination diet and the use of the DBPC challenge to confi rm the diagnosis of gluten hypersensitivity are suggested ( 20 ) . We have used the DBPC-challenge method in numerous studies on patients with suspected food hypersensitivity, as it is considered the gold standard for this diagnosis ( 21, 22 ) . In this study, we reviewed the characteristics of a large group of IBS patients fulfi ling the recent criteria proposed for " gluten sensitivity " who had a diagnosis of wheat hypersensitivity following DBPC challenge.
Our results clearly showed that a relevant percentage -more than one-fourth -of the patients who underwent DBPC wheat challenge were really suff ering from WS.
As regards the clinical characteristics of WS patients and the identifi cation of possible diagnostic markers, our data indicated that the presence of anemia and weight loss and a history of food allergy in infancy and of coexistent atopic diseases were more frequent in WS patients than in IBS controls. As other studies have not shown changes in intestinal permeability and absorption ( 20, 23 ) , it could be hypothesized that the anemia and weight loss may in part depend on the self-restricted diet commenced by the patients, which excluded many foods. Th e other clinical characteristics are very similar to those observed in the allergic patients. Furthermore, the very high frequency of self-reported wheat intolerance, Obviously, other hypotheses must be considered; experimental models have demonstrated that gluten sensitization of DQ8 mice increases acetylcholine release by the myenteric plexus and this can lead to consequent in vivo dysmotility ( 27 ) . In this model, gluten did not cause villous atrophy, but there was evidence that coexistent triggers, e.g., intestine-damaging drugs or dysbacteriosis, can lead to a more severe intestinal impairment ( 28 ) . Clearly, wheat antigens may also act in a similar manner.
Th e second group of patients with WS -those showing multiple food hypersensitivity -showed characteristics more similar to those of allergic rather than of CD patients, although none of them tested positive for IgE-based assays. In accordance with the " allergy hypothesis " , these patients showed a higher frequency of which we observed in our patients, should induce clinicians to pay full attention to patient suggestions.
As regards the serologic assays, we confi rmed that about half of WS patients had positive AGAs ( 20, 24 ) . More interestingly, the in vitro basophil activation assay confi rmed a high sensitivity for WS diagnosis ( 16 ) and further studies would be very useful to confi rm its use, as it seems to be the most accurate marker of WS at present.
Colon histology evaluation showed intra-epithelial and lamina propria infi ltration of EOS in about two-third of cases and this fi nding was also frequently observed in the duodenum, together with lymphocytosis. Th is histology pattern could be another element pointing to a suspected WS diagnosis and the diff use ileum-colon involvement could explain why the main symptoms in these patients were " lower " and not " upper " ones.
However, our data confi rmed the idea that WS is a heterogeneous clinical condition, comprising various subgroups of patients who have diff erent clinical histories and characteristics. In fact, we " identifi ed " at least two distinct kinds of WS: one grouping patients with WS alone and another with subjects intolerant to wheat, cow ' s milk protein, and many other foods. Th ese two groups, in fact, showed a clear variation in presentation and immunological fi ndings, although there was also a signifi cant overlap.
Subjects with WS alone showed a higher frequency of the DQ2 or DQ8 HLA haplotype, duodenal lymphocytosis was seen in 94 % of cases and EmA assay in the culture medium of the duodenal biopsies tested positive in one-third of them. Although we found negative serum anti-tTG and EmA assays and an absence of villous atrophy, a previous study of ours had demonstrated that symptomatic patients who produce EmA in the duodenal culture can subsequently develop villous atrophy when remaining on a gluten-containing diet ( 12 ) and identical fi ndings have been reported for serum EmA-positive patients with an initial evaluation of normal duodenal histology ( 25 ) , as well as for patients without villous atrophy but with immunohistochemical evidence of anti-tTG deposits in the duodenal mucosa ( 26 ) . Th ese fi ndings permitted us to hypothesize that a percentage of these patients could be predisposed to develop villous atrophy -" overt " CD -in the future. However, whether these patients will eventually develop CD remains to be examined in follow-up studies. 
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family and personal history of food allergy and coexistent atopy than the other group. Th eir predominant presence in our study group probably conditioned the results of the immunology assays (positivity of IgG AGA and anti-betalactoglobulin, positivity of basophil activation assay) and of the histology studies (mucosal EOS infi ltration in the duodenum and colon). Further studies are needed to clarify whether this predominant presence of allergiclike patients can be considered a " universal " characteristic of WS. However, the limitations of our study must be underlined. Th is is a retrospective study and the data were not recorded according to a predesigned protocol. Although at least four duodenal biopsy samples were examined, we cannot exclude the possibility that a greater number of biopsy samples could have permitted a CD diagnosis in some cases ( 29 ) . Furthermore, in most of these patients duodenal biopsy was not performed in the bulb and this has recently come to be considered a recommended biopsy site for CD diagnosis ( 30 ) . Duodenal IEL infi ltration can be caused by several factors ( 31, 32 ) and these causes were not all systematically examined. Our series is not composed of consecutive patients as we included only subjects who underwent DBPC challenge. Th is did not permit us to evaluate the respective incidences of the kinds of WS and could have determined a selection bias. As a point of reference, over the last year, taking into consideration both patients tested with open and DBPC challenge, we have diagnosed, in a single center, 46 new CD cases, 15 cases of wheat hypersensitivity alone, and 90 cases with multiple food hypersensitivity. Furthermore, in this study we did not use gluten but wheat for the challenges. Consequently, we cannot exclude the possibility that other components of wheat may be responsible for the pictures we describe: i.e., fructans and poorly absorbed carbohydrates can induce symptoms by themselves ( 33 ) .
In conclusion, our data clearly identifi ed a patient population suff ering from non-CD WS and described their clinical, serological, and histologic characteristics. We also suggest the possibility of distinct populations of subjects with WS: one with characteristics more similar to CD and the other with characteristics strongly pointing to food allergy.
